Hanmi Pharm reports strong 1st-quarter results

Hanmi Pharm, which made new launchings of nefedipine (a generic version of Bayer's Adalat Oros with 25 billion won in sales) and Testogel (testosterone) for men in April, reported a strong performance for its fiscal first quarter and this bullish trend will continue, according to a local bourse said.

For the three months ended in March 31, Hanmi posted sales revenue of 72.7 billion won in th...